Open Access · CC BY 4.0
RETRACTION: Zinc Oxide Nanoparticle Inhibits Tumorigenesis of Renal Cell Carcinoma by Modulating Lipid Metabolism Targeting miR‐454‐3p to Repressing Metabolism Enzyme ACSL4
Journal of Oncology · 2026-01 · 2026 (1)
DOI: 10.1155/jo/9820480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oncology, online erschienen am 03.11.2026. Verfasst von Journal Of Oncology. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Oncology, J. O. (2026). RETRACTION: Zinc Oxide Nanoparticle Inhibits Tumorigenesis of Renal Cell Carcinoma by Modulating Lipid Metabolism Targeting miR‐454‐3p to Repressing Metabolism Enzyme ACSL4. Journal of Oncology, 2026(1). https://doi.org/10.1155/jo/9820480
Vancouver
Oncology JO. RETRACTION: Zinc Oxide Nanoparticle Inhibits Tumorigenesis of Renal Cell Carcinoma by Modulating Lipid Metabolism Targeting miR‐454‐3p to Repressing Metabolism Enzyme ACSL4. Journal of Oncology. 2026;2026(1). doi:10.1155/jo/9820480
BibTeX
@article{Oncology2026,
author = {Oncology, Journal Of},
title = {RETRACTION: Zinc Oxide Nanoparticle Inhibits Tumorigenesis of Renal Cell Carcinoma by Modulating Lipid Metabolism Targeting miR‐454‐3p to Repressing Metabolism Enzyme ACSL4},
journal = {Journal of Oncology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jo/9820480}
}
EUVIMED